Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Combe

Showing results (211-220 of 282) with videos related to

Pageof 29
Sort By:
Joint Bone Spine|June 27, 2007
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionStephan Pavy, Emmanuelle Dernis, Frédéric Lavie, et al.
Annals of the Rheumatic Diseases|June 18, 2014
SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritisPierre-Antoine Juge, Hanna W van Steenbergen, Arnaud Constantin, et al.
Joint Bone Spine|June 26, 2007
Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionEmmanuelle Dernis, Frédéric Lavie, Stéphan Pavy, et al.
Rheumatology (Oxford, England)|September 29, 2017
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATEJacques Morel, Arnaud Constantin, Gabriel Baron, et al.
BMJ (Clinical Research Ed.)|January 26, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort studyJacques-Eric Gottenberg, Jacques Morel, Elodie Perrodeau, et al.
RMD Open|November 28, 2017
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registryCynthia Nourisson, Martin Soubrier, Aurélien Mulliez, et al.
Rheumatology (Oxford, England)|May 7, 2021
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohortBernard Combe, Nathalie Rincheval, Francis Berenbaum, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohortDewi Guellec, Guillermo Carvajal-Alegria, Claire Daïen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trialJérémie Sellam, Sandrine Marion-Thore, Florent Dumont, et al.
Rheumatology and Therapy|December 5, 2020
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)Ana-Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, et al.
Pageof 29

Showing results (211-220 of 282) with videos related to

Sort By:
Pageof 29
Joint Bone Spine|June 27, 2007
Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionStephan Pavy, Emmanuelle Dernis, Frédéric Lavie, et al.
Annals of the Rheumatic Diseases|June 18, 2014
SPP1 rs9138 variant contributes to the severity of radiological damage in anti-citrullinated protein autoantibody-negative rheumatoid arthritisPierre-Antoine Juge, Hanna W van Steenbergen, Arnaud Constantin, et al.
Joint Bone Spine|June 26, 2007
Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinionEmmanuelle Dernis, Frédéric Lavie, Stéphan Pavy, et al.
Rheumatology (Oxford, England)|September 29, 2017
Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATEJacques Morel, Arnaud Constantin, Gabriel Baron, et al.
BMJ (Clinical Research Ed.)|January 26, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort studyJacques-Eric Gottenberg, Jacques Morel, Elodie Perrodeau, et al.
RMD Open|November 28, 2017
Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registryCynthia Nourisson, Martin Soubrier, Aurélien Mulliez, et al.
Rheumatology (Oxford, England)|May 7, 2021
Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohortBernard Combe, Nathalie Rincheval, Francis Berenbaum, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Clinical significance of a self-reported familial occurrence of rheumatoid arthritis among patients with recent-onset arthritis: data from the ESPOIR cohortDewi Guellec, Guillermo Carvajal-Alegria, Claire Daïen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trialJérémie Sellam, Sandrine Marion-Thore, Florent Dumont, et al.
Rheumatology and Therapy|December 5, 2020
Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2)Ana-Maria Orbai, Jordi Gratacós, Anthony Turkiewicz, et al.
Pageof 29